Stock Report

All about this stock under one free report Last Updated: 04-Sep-2026

Stock Rating

Is this stock worth it? Our ratings reveal the truth.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

Curis Lifesciences Key Ratios

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

NSE: CURIS

₹145.10

up-down-arrow ₹3.15 (2.22%)

As on 03-Sep-2026 15:50IST

Market cap

info icon

₹117 Cr

Revenue (TTM)

info icon

₹49 Cr

P/E Ratio

info icon

17

P/B Ratio

info icon

2.5

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -- -- 38.18 27.43 --
EBIT -- -- 14.31 46.09 --
Net Profit -- -- 25.44 131.45 --
EPS -- -- 16.26 125.66 --
Book Value -- -- 156.09 165.16 --
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsMar-25Mar-24Mar-23
EBIT-Margin info 15.73--18.0621.837.29
Net Margin info 10.34--12.3013.575.15
Return on equity info 1,288.87--55.25141.513,669.86
Return on Capital info 31.81--34.2540.2220.96
Return on Assets info 12.61--15.9815.306.56
Debt to Equity (x) info ----0.962.9116.10

Profitability

View Detailed Peer Comparison

ROCE

34.25

Higher than Peers by 17.79

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Curis Lifesciences
34.25
40.22
20.96
17.12
--
Peer Median
16.46
15.49
17.37
17.62
--
ROE

55.25

Higher than Peers by 41.38

Profit after tax / Average Net worth * 100

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Curis Lifesciences
55.25
141.51
3,669.86
--
--
Peer Median
13.87
14.72
15.70
18.36
--
ROA

15.98

Higher than Peers by 7.94

Profit after tax / Average Total assets * 100

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Curis Lifesciences
15.98
15.30
6.56
1.80
--
Peer Median
8.04
7.19
9.43
9.43
--
EBIT Margin

18.06

Higher than Peers by 8.01

Operating profit (EBIT) / Net Sales * 100

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Curis Lifesciences
18.06
21.83
7.29
11.99
--
Peer Median
10.05
10.28
13.90
17.27
--
Net Margin

12.30

Higher than Peers by 3.19

Net profit / Total Income (Net sales plus other income) * 100

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Curis Lifesciences
12.30
13.57
5.15
2.07
--
Peer Median
9.11
6.78
10.91
12.99
--
Cash Profit Margin

13.80

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Curis Lifesciences
13.80
15.60
7.34
5.25
--
Peer Median
--
--
--
--
--

Growth

View Detailed Peer Comparison

Revenue Growth

38.18

Higher than Peers by 31.02

Year on year growth in net sales

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Curis Lifesciences
38.18
0.30
49.29
--
--
Peer Median
7.17
10.56
12.63
15.47
--
EBIT Growth

14.31

Higher than Peers by 2.27

Year on year growth in operating profit (EBIT)

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Curis Lifesciences
14.31
200.18
-9.14
--
--
Peer Median
12.05
6.17
-2.90
51.73
--
Net Profit Growth

25.44

Higher than Peers by 3.29

Year on year growth in profit after tax

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Curis Lifesciences
25.44
159.53
280.85
--
--
Peer Median
22.15
27.97
-14.10
44.15
--
EPS Growth

16.26

Higher than Peers by 7.45

Year on year growth in earnings per share

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Curis Lifesciences
16.26
159.53
280.83
--
--
Peer Median
8.80
--
-3.68
38.52
--
Book Value Growth

176.31

--

Year on year growth in book value per share

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Curis Lifesciences
176.31
483.89
211.31
--
--
Peer Median
--
--
--
--
--

Solvency

View Detailed Peer Comparison

Debt to Equity

0.96

Higher than Peers by 0.93

Total debt / Net worth

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Curis Lifesciences
0.96
2.91
16.10
-19.50
--
Peer Median
0.03
0.05
0.14
0.23
--
Short term debt to equity ratio

0.44

--

(Short term borrowings / Net worth)

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Curis Lifesciences
0.44
1.21
5.06
-3.98
--
Peer Median
--
--
--
--
--
Current Ratio

1.78

Lower than Peers by 0.42

Current Assets / Current Liabilities and Provisions

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Curis Lifesciences
1.78
1.21
0.94
0.94
--
Peer Median
2.20
1.93
1.82
1.75
--
Quick Ratio

0.73

Lower than Peers by 0.98

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Curis Lifesciences
0.73
0.72
0.66
0.60
--
Peer Median
1.72
1.59
1.30
1.04
--
Interest Coverage

8.41

Lower than Peers by 3.88

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Curis Lifesciences
8.41
8.95
2.61
1.75
--
Peer Median
12.28
12.45
16.98
15.07
--

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

15.31

Lower than Peers by 10.92

Debtors outstanding / Net Sales * 100

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Curis Lifesciences
15.31
28.39
26.93
26.30
--
Peer Median
26.23
23.97
24.57
20.26
--
Asset Turnover

1.29

Higher than Peers by 0.55

Sales / Average Total Assets

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Curis Lifesciences
1.29
1.12
1.24
0.87
--
Peer Median
0.74
0.88
0.82
0.79
--
Receivable days

65.45

--

Average Debtors / Sales * 365

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Curis Lifesciences
65.45
100.82
81.29
95.98
--
Peer Median
--
--
--
--
--
Inventory Days

101.63

--

Average Inventory / Sales * 365

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Curis Lifesciences
101.63
72.22
53.97
82.63
--
Peer Median
--
--
--
--
--
Payable days

121.29

--

Average Creditors / Cost of goods sold * 365

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Curis Lifesciences
121.29
274.17
228.97
359.28
--
Peer Median
--
--
--
--
--
Cash Conversion Cycle

45.79

--

Receivable Days + Inventory Days - Payable Days

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Curis Lifesciences
45.79
-101.14
-93.71
-180.68
--
Peer Median
--
--
--
--
--

Valuation

View Detailed Peer Comparison

Price / Earnings

--

--

Current share price divided by earning per share in the last twelve months

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Curis Lifesciences
--
--
--
--
--
Peer Median
39.17
40.74
25.97
33.71
--
Price / Book Value

--

--

Current share price divided by book value per share in the latest financial year

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Curis Lifesciences
--
--
--
--
--
Peer Median
3.61
3.87
2.79
4.36
--
EV/EBITDA

2.11

Lower than Peers by 26.68

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Curis Lifesciences
2.11
1.96
3.86
4.98
--
Peer Median
28.79
25.41
15.07
23.32
--
Market Cap

--

--

Current Share price multiplied by latest total number of shares outstanding

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
Curis Lifesciences
--
--
--
--
--
Peer Median
3,944
2,959
3,742
6,050
--
loading...
loading...
loading...